Eric Warren
Chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS) since March 2026
Eric Warren has filed 42 insider reports with the SEC since March 2022, as chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS) and chief Commercial Officer at Esperion Therapeutics, Inc. (ESPR). In the last 12 months Eric Warren sold $3.3M of stock on the open market. On September 21, 2026 Eric Warren filed a Form 144 notice and plans to sell 7,438 MLYS shares (~$209K). In the latest filing, on September 22, 2026, Eric Warren sold 7,438 shares of Mineralys Therapeutics, Inc. (MLYS) for $209K at an average of $28.12.
Planned sale (Form 144)
- Eric Warren plans to sell 7,438 MLYS shares (~$209K), around Sep 21, 2026. Notice filed Sep 21, 2026.
A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.
- Filings
- 42
- Companies
- 2
- Bought on market
- $7,460
- Sold on market
- $3.36M
Companies where Eric Warren is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Commercial Officersince March 2026 | 38,400 | $3.3M | $14.16 | Sep 22, 2026 | |||
| Chief Commercial Officersince March 2022 | 370,218 | $7,460 | $61.4K | $7.46 | Apr 21, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 21, 2026-$209KMLYSChief Commercial Officer Warren Eric exercised 7,438 shares at a strike of $13.24 and sold $209,136 worth of shares (7,438 units at $28.12) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 21, 2026~$209KMLYSEric Warren plans to sell 7,438 shares (~$209K)Form 144Planned sale10b5-1 plan
- Aug 21, 2026-$193KMLYSChief Commercial Officer Warren Eric exercised 7,437 shares at a strike of $13.24 and sold $193,189 worth of shares (7,437 units at $25.98) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 21, 2026~$193KMLYSEric Warren plans to sell 7,437 shares (~$193K)Form 144Planned sale10b5-1 plan
- Jul 21, 2026-$200KMLYSChief Commercial Officer Warren Eric exercised 7,438 shares at a strike of $13.24 and sold $199,885 worth of shares (7,438 units at $26.87) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 21, 2026~$200KMLYSEric Warren plans to sell 7,438 shares (~$200K)Form 144Planned sale10b5-1 plan
- Jun 26, 2026-$2.7MMLYSChief Commercial Officer Warren Eric exercised 104,124 shares at a strike of $13.24 and sold $2,696,322 worth of shares (104,124 units at $25.90) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 26, 2026~$2.7MMLYSEric Warren plans to sell 104,124 shares (~$2.7M)Form 144Planned sale10b5-1 plan
- Mar 4, 2026MLYSNew insider Warren Eric claimed ownership of 38,400 sharesForm 3New insider
- Apr 17, 2025-$106ESPRChief Commercial Officer Warren Eric sold $106 worth of shares (108 units at $0.98), decreasing direct ownership by 0.03% to 370,218 unitsForm 4Open-market sale
- Mar 18, 2025-$3,618ESPRChief Commercial Officer Warren Eric sold $3,618 worth of shares (2,433 units at $1.49), decreasing direct ownership by 0.65% to 370,326 unitsForm 4Open-market sale
- Mar 14, 2025ESPRChief Commercial Officer Warren Eric was granted 213,000 shares, increasing direct ownership by 133% to 372,759 unitsForm 4Grant or award
- Feb 19, 2025-$446ESPRChief Commercial Officer Warren Eric sold $446 worth of shares (239 units at $1.87), decreasing direct ownership by 0.15% to 159,759 unitsForm 4Open-market sale
- Jan 17, 2025-$278ESPRChief Commercial Officer Warren Eric sold $278 worth of shares (123 units at $2.26), decreasing direct ownership by 0.08% to 159,998 unitsForm 4Open-market sale
- Jan 17, 2025~$278ESPREric Warren plans to sell 123 shares (~$278)Form 144Planned sale
- Dec 17, 2024-$5,426ESPRChief Commercial Officer Warren Eric sold $5,426 worth of shares (2,234 units at $2.43), decreasing direct ownership by 1% to 160,121 unitsForm 4Open-market sale
- Nov 19, 2024-$427ESPRChief Commercial Officer Warren Eric sold $427 worth of shares (197 units at $2.17), decreasing direct ownership by 0.12% to 162,355 unitsForm 4Open-market sale
- Oct 17, 2024-$227ESPRChief Commercial Officer Warren Eric sold $227 worth of shares (107 units at $2.12), decreasing direct ownership by 0.07% to 162,552 unitsForm 4Open-market sale
- Sep 17, 2024-$4,650ESPRChief Commercial Officer Warren Eric sold $4,650 worth of shares (2,608 units at $1.78), decreasing direct ownership by 2% to 162,659 unitsForm 4Open-market sale
- Aug 19, 2024-$411ESPRChief Commercial Officer Warren Eric sold $411 worth of shares (211 units at $1.95), decreasing direct ownership by 0.13% to 165,267 unitsForm 4Open-market sale
- Jul 17, 2024-$279ESPRChief Commercial Officer Warren Eric sold $279 worth of shares (108 units at $2.59), decreasing direct ownership by 0.07% to 165,478 unitsForm 4Open-market sale
- Jun 18, 2024-$7,254ESPRChief Commercial Officer Warren Eric sold $7,254 worth of shares (2,540 units at $2.86), decreasing direct ownership by 2% to 165,586 unitsForm 4Open-market sale
- May 17, 2024-$477ESPRWarren Eric sold $477 worth of shares (192 units at $2.48), decreasing direct ownership by 0.11% to 168,126 unitsForm 4Open-market sale
- Mar 14, 2024ESPRWarren Eric was granted 100,000 shares, increasing direct ownership by 146% to 168,318 unitsForm 4Grant or award
- Sep 20, 2023-$924ESPRSEC Form 4: Warren Eric sold $924 worth of shares (742 units at $1.25), decreasing direct ownership by 1% to 68,318 unitsForm 4Open-market sale
- Aug 18, 2023-$344ESPRSEC Form 4: Warren Eric sold $344 worth of shares (243 units at $1.41), decreasing direct ownership by 0.35% to 69,060 unitsForm 4Open-market sale
- Jul 19, 2023-$168ESPRSEC Form 4 filed by Warren EricForm 4Open-market sale
- Jun 21, 2023-$894ESPRSEC Form 4 filed by Warren EricForm 4Open-market sale
- May 17, 2023-$356ESPRSEC Form 4 filed by Warren EricForm 4Open-market sale
- Apr 19, 2023-$147ESPRSEC Form 4 filed by Warren EricForm 4Open-market sale
- Mar 14, 2023ESPRSEC Form 4: Warren Eric was granted 22,300 shares, increasing direct ownership by 46% to 70,872 unitsForm 4Grant or award
- Mar 7, 2023-$25.7KESPRSEC Form 4: Warren Eric sold $25,730 worth of shares (5,090 units at $5.05), decreasing direct ownership by 9% to 48,572 unitsForm 4Open-market sale
- Oct 18, 2022-$823ESPRSEC Form 4: Warren Eric sold $823 worth of shares (107 units at $7.69), decreasing direct ownership by 0.20% to 53,662 unitsForm 4Open-market sale
- Sep 19, 2022-$1,765ESPRSEC Form 4: Warren Eric sold $1,765 worth of shares (255 units at $6.92), decreasing direct ownership by 0.47% to 53,769 unitsForm 4Open-market sale
- Aug 31, 2022+$7,460ESPRSEC Form 4: Warren Eric bought $7,460 worth of shares (1,000 units at $7.46), increasing direct ownership by 2% to 54,024 unitsForm 4Open-market purchase
- Aug 17, 2022-$1,356ESPRSEC Form 4: Warren Eric sold $1,356 worth of shares (199 units at $6.82), decreasing direct ownership by 0.37% to 53,024 unitsForm 4Open-market sale
- Jul 19, 2022-$2,837ESPRSEC Form 4: Warren Eric sold $2,837 worth of shares (431 units at $6.58), decreasing direct ownership by 0.80% to 53,223 unitsForm 4Open-market sale
- Jun 17, 2022-$1,254ESPRSEC Form 4: Warren Eric sold $1,254 worth of shares (256 units at $4.90), decreasing direct ownership by 0.47% to 53,654 unitsForm 4Open-market sale
- Jun 7, 2022ESPRSEC Form 4 filed by Warren EricForm 4Grant or award
- May 17, 2022-$1,172ESPRSEC Form 4: Warren Eric sold $1,172 worth of shares (196 units at $5.98), decreasing direct ownership by 0.36% to 53,910 unitsForm 4Open-market sale
- Mar 14, 2022ESPRSEC Form 4: Warren Eric was granted 13,000 shares, increasing direct ownership by 32% to 54,106 unitsForm 4Grant or award
- Mar 1, 2022ESPRSEC Form 3: New insider Warren Eric claimed ownership of 41,106 sharesForm 3New insider
Compare Eric Warren with
- Eric Warren vs Jon Congleton1 shared
- Eric Warren vs Brian Taylor Slingsby1 shared
- Eric Warren vs Daphne Karydas1 shared
- Eric Warren vs David Malcom Rodman1 shared
- Eric Warren vs James J. Ferguson III1 shared
- Eric Warren vs Robert E. Hoffman1 shared
Other insiders at the same companies
- Jon CongletonMLYS
- Brian Taylor SlingsbyMLYS
- Catalys Pacific Fund LPMLYS
- Daphne KarydasMLYS
- David Malcom RodmanMLYS
- James J. Ferguson IIIMLYS
- Robert E. HoffmanESPR
- J Martin CarrollESPR
- Jay ShepardESPR
- Fischer Seth H. Z.ESPR
- John Craig ThompsonESPR
- John B. Harlow Jr.ESPR
- Benjamin LookerESPR
- Benjamin HalladayESPR
- Sheldon L. KoenigESPR
- Ra Capital Management, L.P.MLYS
Questions about Eric Warren
- What is Eric Warren's role at Mineralys Therapeutics, Inc.?
- Eric Warren reports to the SEC as chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS), according to the latest filing on September 22, 2026. Eric Warren has also filed as chief Commercial Officer at Esperion Therapeutics, Inc. (ESPR).
- How many shares does Eric Warren own?
- After the latest filing that states it, Eric Warren directly owned 38,400 shares of Mineralys Therapeutics, Inc. (MLYS) and 370,218 shares of Esperion Therapeutics, Inc. (ESPR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eric Warren bought or sold stock recently?
- The most recent open-market purchase was on August 31, 2022: bought 1,000 shares of Esperion Therapeutics, Inc. (ESPR) for $7,460 at an average of $7.46. The most recent open-market sale was on September 21, 2026: sold 7,438 shares of Mineralys Therapeutics, Inc. (MLYS) for $209K at an average of $28.12.
- How do I get alerts when Eric Warren files?
- Follow Eric Warren on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Eric Warren filed 3 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Eric Warren (SEC CIK 0001916048). Totals count each trade once, skipping amendments whose original is on file, from Mar 9, 2022 on. View on SEC EDGAR · Get this as JSON